Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/146969
Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
The relationship between oral contraceptives (OCs), menopausal hormone replacement therapy (HRT) and the risk of colorectal cancer was investigated in a case-control study conducted in northern Italy between 1985 and 1992 on 709 women with incident colorectal cancer and 992 controls admitted to hospital for a wide spectrum of acute, non-neoplastic, non-digestive tract, non-hormone-related disorders. A reduced risk of colorectal cancer was observed in women who had ever used OCs [multivariate odds ratio (OR) = 0.58; 95% confidence interval (CI): 0.36-0.92]. The OR was 0.52 (95% CI 0.27-1.02) for use over 2 years. For women ever using HRT, the multivariate OR was 0.40 (95% CI 0.25-0.66). The risk was inversely related to duration of use, with ORs of 0.46 for 2 years or less and 0.25 for more than 2 years of use. No consistent pattern of trends was observed with time since first or last use. This study provides further evidence that OC and HRT do not increase, and possibly decrease, the risk of colorectal cancer. These results, if confirmed, would have important implications for the ultimate risk-benefit assessment of female hormone preparations.
Matèries (anglès)
Citació
Citació
FERNÁNDEZ MUÑOZ, Esteve, LA VECCHIA, Carlo, D'AVANZO, Barbara, FRANCESCHI, Silvia, NEGRI, Eva, PARAZZINI, Fabio. Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. _British Journal of Cancer_. 1996. Vol. 73, núm. 11, pàgs. 1431-1435. [consulta: 23 de gener de 2026]. ISSN: 0007-0920. [Disponible a: https://hdl.handle.net/2445/146969]